Skip to main content
. 2020 Jul 27;10(7):e038432. doi: 10.1136/bmjopen-2020-038432

Table 1.

Baseline characteristics among CNSD users and non-users

Characteristics CNSD non-users
(n=146 to 59.3 %)
CNSD users
(n=100 to 40.7 %)
P value
Females, N (%) 71 (49%) 66 (66%) 0.007
Age at screening, mean (SD) 75.3 (6.4) 78.6 (6.5) <0.001*
Education, mean (SD) 13.6 (2.9) 12.6 (3.2) 0.011*
AUDIT, mean (SD) 2.7 (3.2) 2.2 (3.1) 0.171*
Smoking, N (% No) 105 (72%) 70 (70%) 0.692†
HADS depression, mean (SD)
HADS anxiety, mean (SD)
HADS total score, mean (SD)
3.6 (3.0)
4.1 (3.3)
7.7 (5.3)
5.1 (3.5)
5.0 (3.9)
10.1 (6.7)
<0.001*
0.094*
0.003*
CIRS-G mean (SD) 4.7 (2.1) 7.7 (2.7) <0.001*
Cognistat mean, (SD)** 71.5 (5.9) 66.5 (7.7)   ‡
MMSE mean, (SD)** 25.7 (2.7) 24.8 (2.6)   ‡
Clock mean, (SD)** 4.2 (1.3) 3.4 (1.4)   ‡
TMT-A, mean (sec), (SD) 78.6 (48.2) 90.9 (51.2)   ‡
TMT-B, mean (sec), (SD) 181.3 (100.6) 214.9 (107.0)   ‡

**p value ≤0.05. The data is presented as mean and SD or number of patients (N) and percentage (%).

*t-test table 2

†χ2 (Missing: CIRS-G=1, HADS=17, smoking=40, education=10, AUDIT=22). The Neurobehavioural Cognitive Status Examination (Cognistat)=145; MMSE=33; Clock drawing test (Clock)=88 TMT A and B=133/139).

‡p value presented in table 2 in bivariate model.

AUDIT, alcohol use and disorder identification test; CIRS-G, cumulative illness rating score geriatrics; CNSD, central nervous system depressant; HADS, hospital anxiety and depression scale; MMSE, mini-mental state examination; sec, secondary; TMT, trail making test.